Corebridge Financial vs MetLife
CRBG and MET side by side, both in life insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRBG and MET compare
MetLife is the larger company, worth 4.1 times as much as Corebridge Financial ($64.5B against $15.6B).
Corebridge Financial grew revenue faster over the last twelve months (29.5% versus 14.8% for MetLife).
MetLife keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 4.5% at Corebridge Financial.
Both pay dividends: Corebridge Financial yields 2.8% and MetLife 1.7%.
MetLife scores higher on the StockData Score (10 against 5 for Corebridge Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRBG | MET |
|---|---|---|
| Size and price | ||
| Market cap | $15.6B | $64.5B |
| Share price | $34.93 | $101.50 |
| Change, 1 year | 20.0% | 29.1% |
| Change, 5 years | – | 68.9% |
| Beta (5Y) | 1.38 | 0.68 |
| Employees | 4,800 | 46K |
| StockData Score | ||
| Total score | 5 | 10 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 2 | 2 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | – | 13.2× |
| P/S | 0.8× (better) | 0.8× |
| P/B | 1.5× (better) | 2.9× |
| EV/EBITDA | 7.4× | 5.6× (better) |
| Fair value | – | $74.02 |
| Margin of safety | – | −37.1% |
| Growth | ||
| Revenue growth (TTM) | 29.5% (better) | 14.8% |
| Revenue growth, 5Y average | 4.2% (better) | 2.6% |
| Net income growth (TTM) | – | 33.5% |
| EPS growth (TTM) | – | 44.4% |
| EPS growth, 5Y average | – | −3.7% |
| Profitability | ||
| Operating margin | – | 8.2% |
| Net margin | 4.5% | 6.2% (better) |
| Return on equity | 7.9% | 20.0% (better) |
| Financial health | ||
| Debt / equity | 0.12 | 0.01 (better) |
| Net debt / EBITDA | 0.39 (better) | −4.06 |
| Altman Z-score | 0.13 | 0.28 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.8% (better) | 1.7% |
| Payout ratio | 52.1% | 29.4% |
| Years of dividend growth | – | 13 |
| Dividend growth, 5Y average | – | 4.3% |
| Buyback yield | 19.5% (better) | 4.0% |
| Shareholder yield | 22.3% (better) | 5.7% |
| Ownership | ||
| Held by institutions | 109% | 76.5% |
| Held by insiders | 46.3% | 16.1% |
| Insider net buying, 12 months | −$977M | −$21.0M (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | – | 2.0% |
Go deeper
- CRBG stock overview
- CRBG income statement
- CRBG valuation and score
- MET stock overview
- MET income statement
- MET valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.